BAKER BROS ADVISORS LLC Insider Trading $PRLD Prelude Therapeutics Inc
Get free email notifications about insider trading for BAKER BROS ADVISORS LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of BAKER BROS ADVISORS LLC. BAKER BROS ADVISORS LLC is 10% Owner in BIOCRYST PHARMACEUTICALS INC ($BCRX) and Director in INCYTE CORP ($INCY) and Director in ALEXION PHARMACEUTICALS INC ($ALXN) and 10% Owner in IDERA PHARMACEUTICALS, INC. ($IDRA) and Director in IDERA PHARMACEUTICALS, INC. ($IDRA) and in XOMA Corp ($XOMA) and Director in ACADIA PHARMACEUTICALS INC ($ACAD) and Director in SEATTLE GENETICS INC /WA ($SGEN) and Director in GENOMIC HEALTH INC ($GHDX) and 10% Owner in BELLICUM PHARMACEUTICALS, INC ($BLCM) and 10% Owner in AQUINOX PHARMACEUTICALS, INC ($AQXP) and Director in AQUINOX PHARMACEUTICALS, INC ($AQXP) and Director in Zymeworks Inc. ($ZYME) and Director in Kodiak Sciences Inc. ($KOD) and 10% Owner in Invitae Corp ($NVTA) and Director in IGM Biosciences, Inc. ($IGMS) and 10% Owner in Atreca, Inc. ($BCEL) and in Mirati Therapeutics, Inc. ($MYG) and 10% Owner in Mirati Therapeutics, Inc. ($MYG) and Director in Talis Biomedical Corp ($TLIS) and Director in Aeglea BioTherapeutics, Inc. ($AGLE) and in RHYTHM PHARMACEUTICALS, INC. ($RYTM) and in Intellia Therapeutics, Inc. ($NTLA) and Director in BeiGene, Ltd. ($BGNE) and Director in Prelude Therapeutics Inc ($PRLD) and Director in Kiniksa Pharmaceuticals, Ltd. ($KNSA) and in HOOKIPA Pharma Inc. ($HOOK).
BAKER BROS ADVISORS LLC in Prelude Therapeutics Inc
Trading Symbol: PRLDIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BAKER BROS ADVISORS LLC: Director
Holdings: 876,061 shares
Latest Transaction: Jan 29 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of BAKER BROS ADVISORS LLC in Prelude Therapeutics Inc
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ACAD, AGLE, ALXN, BCEL, BGNE, BLCM, BCRX, GHDX, HOOK, IDRA, IGMS, INCY, NTLA, NVTA, KNSA, KOD, MYG, NLTX, PRLD, RYTM, SGEN, TLIS, XOMA, ZYME
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 29 2021 | PRLD | Prelude Therapeuti ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 12.85 | 5,188 | 66,666 | 41,500 | |
Jan 29 2021 | PRLD | Prelude Therapeuti ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | M | 12.85 | 5,188 | 66,666 | 41,500 | |
Jan 29 2021 | PRLD | Prelude Therapeuti ... | BAKER BROS. ADVISORS LP | Director | Buy | M | 12.85 | 5,188 | 66,666 | 9,252,951 | 9.2 M to 9.3 M (+0.06 %) |
Jan 29 2021 | PRLD | Prelude Therapeuti ... | BAKER BROS. ADVISORS LP | Director | Buy | M | 12.85 | 5,188 | 66,666 | 876,061 | 870.9 K to 876.1 K (+0.60 %) |
Jan 13 2021 | PRLD | Prelude Therapeuti ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | P | 0.00 | 154,222 | 0 | 5,212,371 | |
Jan 13 2021 | PRLD | Prelude Therapeuti ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | P | 0.00 | 12,444 | 0 | 509,480 | |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | C | 0.00 | 382,884 | 0 | 5,058,149 | |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | C | 0.00 | 382,884 | 0 | 0 | |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | C | 0.00 | 30,349 | 0 | 497,036 | |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | C | 0.00 | 30,349 | 0 | 0 | |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | C | 0.00 | 574,327 | 0 | 0 | |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | C | 0.00 | 45,524 | 0 | 0 | |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | C | 0.00 | 2,698,424 | 0 | 4,675,265 | |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | C | 0.00 | 2,698,424 | 0 | 0 | |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | C | 0.00 | 247,034 | 0 | 466,687 | |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | C | 0.00 | 247,034 | 0 | 0 | |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | C | 0.00 | 4,047,634 | 0 | 0 | |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | C | 0.00 | 370,552 | 0 | 0 | |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | C | 0.00 | 1,976,841 | 0 | 1,976,841 | |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | C | 0.00 | 1,976,841 | 0 | 0 | |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | C | 0.00 | 219,653 | 0 | 219,653 | |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | C | 0.00 | 219,653 | 0 | 0 | |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | C | 0.00 | 2,965,263 | 0 | 0 | |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | C | 0.00 | 329,478 | 0 | 0 | |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | A | 12.85 | 46,688 | 599,941 | 46,688 | |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | P | 0.00 | 957,211 | 0 | 957,211 | |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | P | 0.00 | 75,873 | 0 | 75,873 | |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | P | 0.00 | 3,373,029 | 0 | 3,373,029 | |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | BAKER BROS. ADVISORS LP | Director | Option Exercise | P | 0.00 | 308,793 | 0 | 308,793 | |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 19.00 | 1,474,319 | 28,012,061 | 9,247,763 | 7.8 M to 9.2 M (+18.97 %) |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | BAKER BROS. ADVISORS LP | Director | Buy | P | 19.00 | 104,628 | 1,987,932 | 870,873 | 766.2 K to 870.9 K (+13.65 %) |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | BAKER BROS. ADVISORS LP | Director | Buy | C | 0.00 | 574,327 | 0 | 7,773,444 | 7.2 M to 7.8 M (+7.98 %) |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | BAKER BROS. ADVISORS LP | Director | Buy | C | 0.00 | 45,524 | 0 | 766,245 | 720.7 K to 766.2 K (+6.32 %) |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | BAKER BROS. ADVISORS LP | Director | Buy | C | 0.00 | 4,047,634 | 0 | 7,199,117 | 3.2 M to 7.2 M (+128.44 %) |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | BAKER BROS. ADVISORS LP | Director | Buy | C | 0.00 | 370,552 | 0 | 720,721 | 350.2 K to 720.7 K (+105.82 %) |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | BAKER BROS. ADVISORS LP | Director | Buy | C | 0.00 | 2,965,263 | 0 | 3,151,483 | 186.2 K to 3.2 M (+1,592.34 %) |
Sep 30 2020 | PRLD | Prelude Therapeuti ... | BAKER BROS. ADVISORS LP | Director | Buy | C | 0.00 | 329,478 | 0 | 350,169 | 20.7 K to 350.2 K (+1,592.37 %) |
Page: 1